Table 2.
Patient characteristics by WMC follow-up or not
| Follow-up in first 15 months | |||
|---|---|---|---|
| Variable | Overall, N = 159a | No, N = 30a | Yes, N = 129a |
| Age (y) | 53 (44, 62) | 54 (48, 62) | 53 (44, 62) |
| Sex | |||
| Female | 52 (33%) | 10 (33%) | 42 (33%) |
| Male | 107 (67%) | 20 (67%) | 87 (67%) |
| Race/ethnicity | |||
| Non-Hispanic White | 109 (69%) | 16 (53%) | 93 (72%) |
| Non-Hispanic Black | 30 (19%) | 9 (30%) | 21 (16%) |
| Hispanic | 11 (6.9%) | 5 (17%) | 6 (4.7%) |
| Other | 3 (1.9%) | 0 (0%) | 3 (2.3%) |
| Unknown | 6 (3.8%) | 0 (0%) | 6 (4.7%) |
| Initial weight (kg) | 119 (103, 135) | 120 (105, 134) | 119 (103, 135) |
| BMI | 39 (35, 45) | 40 (35, 42) | 38 (35, 45) |
| BMI categories | |||
| ≥27-<30 | 5 (3.1%) | 1 (3.3%) | 4 (3.1%) |
| ≥30-<35 | 36 (23%) | 5 (17%) | 31 (24%) |
| ≥35-<40 | 49 (31%) | 8 (27%) | 41 (32%) |
| ≥40 | 69 (43%) | 16 (53%) | 53 (41%) |
| Hemoglobin A1c | 5.80 (5.50, 6.40) | 5.80 (5.50, 6.20) | 5.75 (5.43, 6.40) |
| Diabetes | |||
| No | 72 (45%) | 14 (47%) | 58 (45%) |
| Prediabetes | 39 (25%) | 8 (27%) | 31 (24%) |
| T2DM | 48 (30%) | 8 (27%) | 40 (31%) |
| Hypertension | 84 (53%) | 18 (60%) | 66 (51%) |
| Hyperlipidemia | 98 (62%) | 18 (60%) | 80 (62%) |
| OSA | 46 (29%) | 10 (33%) | 36 (28%) |
| Initial AOM | |||
| Orlistat | 19 (12%) | 3 (10%) | 16 (12%) |
| PHEN/TOP | 81 (51%) | 12 (40%) | 69 (53%) |
| Liraglutide | 40 (25%) | 3 (10%) | 37 (29%) |
| Lorcaserin | 9 (5.7%) | 2 (6.7%) | 7 (5.4%) |
| Did not qualify | 10 (6.3%) | 10 (33%) | 0 (0%) |
| AOM E-consult | 94 (59%) | 17 (57%) | 77 (60%) |
| Pre-WMC weight loss (%) in MOVE! | 0.1 (−2.1, 2.2) | 0.1 (−1.5, 1.4) | 0.1 (−2.2, 2.2) |
| Pre-WMC days in MOVE! | 204 (151, 306) | 193 (150, 352) | 204 (152, 302) |
Abbreviations: AOM, antiobesity medication; BMI, body mass index; OSA, obstructive sleep apnea; PHEN/TOP, phentermine/topiramate ER; T2DM, type 2 diabetes mellitus; WMC, pharmacotherapy-weight management clinic.
Wilcoxon rank-sum test, Pearson chi-squared test, or Fisher exact test was performed for each variable, all had P > .05 except race/ethnicity (P < .05) and initial AOM (P < .001). Desired weight loss (%) not available for 30 patients (21 with follow-up, 9 without follow-up).
a Median (interquartile range); n (%).